Source: http://www.wvlegislature.gov/Bill_Text_HTML/2014_SESSIONS/RS/Bills/SB1%20SUB1.htm
Timestamp: 2020-02-23 21:08:30
Document Index: 668810253

Matched Legal Cases: ['§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60']

(By Senators Stollings, Jenkins, Miller, Laird and Plymale)
reported January 29, 2014.]
A BILL to amend and reenact §60A-1-101 of the Code of West Virginia, 1931, as amended; to amend and reenact §60A-2-204, §60A-2-206, §60A-2-208, §60A-2-210 and §60A-2-212 of said code; and to amend and reenact §60A-3-308 of said code, all relating generally to controlled substances; modifying scheduled controlled substances; modifying and including definitions; updating West Virginia schedules of controlled substances; and modifying manner in which buprenorphine and naloxone may be prescribed.
That §60A-1-101 of the Code of West Virginia, 1931, as amended, be amended and reenacted; that §60A-2-204, §60A-2-206, §60A-2-208, §60A-2-210 and §60A-2-212 of said code be amended and reenacted; and that §60A-3-308 of said code be amended and reenacted, all to read as follows:
(d) (D) (dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzol[c]chromen-1-ol) {also known as HU-211};
(e) Notwithstanding any provision of this code to the contrary, on or after September 1, 2012, any practitioner or entity prescribing or dispensing a combination of buprenorphine and naloxone to treat opioid addiction shall only not prescribe or dispense said product in the form of sublingual film unless the sublingual film is clinically contraindicated necessary. If the prescriber or dispenser determines that sublingual film is contraindicated clinically necessary he or she shall document the reasons for not dispensing sublingual film in the
patient’s file or chart.